CP Reports Store
Welcome to the home of CP Reports, we are the only publisher of life science deal term reports in the industry.
CP Reports Store offers over 100 report titles that focus upon different deal types and technology or therapy areas including licensing, collaborative R&D, co-promotion, biomarkers, diagnostics, oncology, immunology all of which provide a detailed insight into the latest life science deal making trends.
Browse our reports by type to find your ideal match.
- Deal type reports
- Industry sector reports
- Stage partnered reports
- Technology reports
- Therapy reports
- Subscription services
Our reports are updated regularly and include full coverage of the latest deals in the chosen report type.
Unsure which report to select? Contact our report analysts who will assist your decision.
-
Diagnostic Collaboration and Licensing Deals 2019-2024May 2024$3,995.00Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Drug Delivery Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Drug Delivery Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Infectious Vaccine Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Regenerative Medicine Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Regenerative Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Antibiotic Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Antibiotic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Cancer Diagnostic Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Cancer Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Gene Therapy Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Gene Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Diagnostic Imaging Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Diagnostic Imaging Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
